Maxlinear, Inc. (MXL) stock forecast and price target
Price $55.78 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($55.78)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $1.99 | +542.6% | $774M |
| Next fiscal year ends December 31, 2027 | $4.30 | +115.8% | $1.3B |
| Next quarter ends December 31, 2026 | $0.79 | +313.7% | $250M |
| Quarter after ends March 31, 2027 | $0.95 | +329.6% | $286M |
Consensus of the analysts covering Maxlinear, updated daily. In the last 30 days 9 estimates were raised and 0 lowered.
Our model vs. Wall Street
Analysts see 67.9% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Maxlinear’s intrinsic value about 88% below today’s market value, and it scores 1.0 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Maxlinear stock price target?
The average 12-month target from 11 analysts is $93.64, 67.9% above the current price of $55.78 Targets range from $40.00 to $125.00.
Is Maxlinear a buy according to analysts?
The consensus rating is “None” (1 strong buy, 6 buy, 4 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Maxlinear expected to earn?
Analysts expect EPS of $1.99 for the fiscal year ending December 31, 2026 and $4.30 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.